HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yiyu Chen Selected Research

ruzinurad

1/2022Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yiyu Chen Research Topics

Disease

11Neoplasms (Cancer)
03/2024 - 10/2013
4Neoplasm Metastasis (Metastasis)
11/2023 - 10/2017
2Breast Neoplasms (Breast Cancer)
01/2023 - 01/2022
2Carcinogenesis
01/2023 - 04/2016
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2021 - 01/2018
2Choriocarcinoma
03/2021 - 01/2020
2Adenocarcinoma of Lung
10/2017 - 01/2015
1Colonic Neoplasms (Colon Cancer)
11/2023
1Fibrosis (Cirrhosis)
11/2023
1Non-alcoholic Fatty Liver Disease
11/2023
1Hepatocellular Carcinoma (Hepatoma)
11/2023
1Lung Diseases (Lung Disease)
01/2023
1Lung Neoplasms (Lung Cancer)
01/2023
1Immediate Hypersensitivity
03/2022
1Hyperuricemia
01/2022
1Gout
01/2022
1Hypoxia (Hypoxemia)
03/2021
1Pathologic Processes
03/2021
1Colorectal Neoplasms (Colorectal Cancer)
01/2020
1Central Nervous System Cavernous Hemangioma
01/2012
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2009
1Acute Promyelocytic Leukemia
07/2009

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
03/2021 - 01/2012
3MicroRNAs (MicroRNA)IBA
11/2023 - 10/2013
3CateninsIBA
07/2021 - 10/2017
3Cisplatin (Platino)FDA LinkGeneric
01/2020 - 10/2017
2GoldIBA
03/2024 - 01/2023
2Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
11/2023 - 01/2023
1Adenosine Monophosphate (AMP)IBA
03/2024
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2023
1Metal-Organic FrameworksIBA
11/2023
1PorphyrinsIBA
11/2023
1Programmed Cell Death 1 ReceptorIBA
11/2023
1Competitive Endogenous RNAIBA
11/2023
1Biomarkers (Surrogate Marker)IBA
11/2023
1Long Noncoding RNAIBA
11/2023
1Therapeutic UsesIBA
11/2023
1manganese oxide (hausmannite)IBA
11/2023
1ferric oxide (iron oxide)IBA
11/2023
1Phenobarbital (Luminal)FDA Link
01/2023
1Glutathione (Reduced Glutathione)IBA
01/2023
1Hydroxyl RadicalIBA
01/2023
1Sulfides (Thioethers)IBA
01/2023
11-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2023
1Tumor Biomarkers (Tumor Markers)IBA
01/2023
1cupric sulfide (CuS)IBA
01/2023
1CopperIBA
01/2023
1Immunoglobulin E (IgE)IBA
03/2022
1FebuxostatFDA Link
01/2022
1ruzinuradIBA
01/2022
1Uric Acid (Urate)IBA
01/2022
1cobaltous chloride (cobalt(II)chloride)IBA
03/2021
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
03/2021
1ErbB Receptors (EGF Receptor)IBA
01/2020
1NicotineFDA Link
01/2020
1Small Interfering RNA (siRNA)IBA
01/2020
1CarcinogensIBA
01/2020
1Cyclin D1IBA
01/2015
1Messenger RNA (mRNA)IBA
01/2015
1Indicators and Reagents (Reagents)IBA
01/2015
1RetinoidsIBA
07/2009
1Vitamin A (Retinol)FDA LinkGeneric
07/2009
1Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2009
1AcidsIBA
07/2009

Therapy/Procedure

5Therapeutics
03/2024 - 01/2018
2Photothermal Therapy
01/2023 - 01/2022
1Lasers (Laser)
03/2024
1Precision Medicine
12/2023
1Photochemotherapy (Photodynamic Therapy)
01/2023
1Drug Therapy (Chemotherapy)
04/2016